Clinical Trial Update: NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE [Phase 2]

View source ↗

Summary

Phase 2 trial update on intravenous immunoglobulins to treat severe COVID-19 with acute respiratory failure in patients aged 75 and over.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure

Drugs mentioned

• Normal Human Immunoglobulins (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Versailles Hospital | Conditions: Sars-CoV2 | Phase 2 | Status: UNKNOWN